NCT00001784View on ClinicalTrials.gov

Mexiletine for the Treatment of Focal Dystonia

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 1998

Study Completion Date

July 31, 2002

Conditions
BlepharospasmDystoniaSpasm
Interventions
DRUG

Mexiletine

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00001784 - Mexiletine for the Treatment of Focal Dystonia | Biotech Hunter | Biotech Hunter